Tuberculosis resistente y extrapulmonar: dos retos para el médico de hoy
Resistant and extrapulmonary tuberculosis: two challenges for today’s clinician
Contenido principal del artículo
Descargas
Detalles del artículo
Referencias (VER)
Farga V, Caminero J. Tuberculosis. Tercera edición 2011. Santiago,
Buenos Aires: Editorial Mediterráneo.
Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation. 2005;112:3608-16.
Pandie S, Peter J, Kerbelker Z. BMC Medicine. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study. BMC Medicine 2014;12:101.
Torres C, Awad C, Dennis R. Guía para el manejo programático de pacientes con tuberculosis farmacorresistente en Colombia 2012. Bogotá: Ministerio de la Protección Social, Fundación Neumológica Colombiana, Instituto Nacional de Salud. Organización Panamericana de la Salud.
Keshavjee S, Farmer P. Tuberculosis, Drug resistance, and the history of modern medicine. N Engl J Med. 2012;367:931-6.
Caminero J. Multidrug-resistant tuberculosis: epidemiology, risk factor and case finding. Int J Tuberc Lung Dis. 2010;14:382-390.
Yew W, Zhang Y. Mechanism of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009;13:1320-1330.
Cuevas C; Zenteno R. tuberculosis drogorresistente: mecanismos moleculares y métodos diagnósticos. Enferm Infecc Microbiol Clin. 2010;28:6221-628.
Van rie A, Page L, Scott L. Xpert MTB/RIF for point of care diagnosis of TB in high HIV burden, resource–limited countries: hype o hope? Expert Rev Mol Diagn. 20101;10:937-946.
Lawn S, Nicol M, Xpert MTB/RIF assay: Development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6:1067-1082.
Boehme C, Nabeta P, Hillemann D. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005-1015.
Arentz M, Sorensen B, Horne DJ, Walson JL. Systematic review of the performance of rapid rifampicin resistance testing for drug-resistant tuberculosis. Plos One. 2013;8:e76533.
Vigneshwaran M, Wang S, Inci F, De Libero G. Emerging technologies for monitoring drug-resistant tuberculosis and the point-of-care. Adv Drug Deliv Rev. 2014 (in Press).
Georghiou S, Magana M, Garfein R, Catanzaro D, Cantanzaro A. Evaluation of genetic mutations associates with Mycobacterium tuberculosis resistance to amikacina, kanamycin, capreomycin: a systematic review. Plos ONE. 2012;7:e33275.